Women's Health Collection

Journal article

Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol

Abstract:: Peer reviewedPublisher PD

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Horne, A. W., Skubisz, M. M., Doust, A., Duncan, W. C., Wallace, E., Critchley, H. O. D., Johns, T. G., Norman, J. E., Bhattacharya, S., Mollison, J., Rassmusen, M., & Tong, S. (2013). Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol. BMJ Open, 3(7), e002902–e002902.

MLA Style

Horne, AW, et al. “Phase II Single Arm Open Label Multicentre Clinical Trial to Evaluate the Efficacy and Side Effects of a Combination of Gefitinib and Methotrexate to Treat Tubal Ectopic Pregnancies (GEM II): Study Protocol.” BMJ Open, vol. 3, no. 7, 2013, pp. e002902–e002902.

Chicago Style

Horne, AW, MM Skubisz, A Doust, et al. 2013. “Phase II Single Arm Open Label Multicentre Clinical Trial to Evaluate the Efficacy and Side Effects of a Combination of Gefitinib and Methotrexate to Treat Tubal Ectopic Pregnancies (GEM II): Study Protocol.” BMJ Open 3 (7): e002902–e002902.
Print

Access Document

Files:: Horne_et_al_2013_Phase_II_single.pdf

(Preview, Version of record, pdf, 238.4KB, Terms of use)

Publisher copy:: 10.1136/bmjopen-2013-002902

Authors

+ Horne, AW More by this author

Role:: Author
ORCID:: 0000-0002-9656-493X

+ Skubisz, MM More by this author

Role:: Author

+ Doust, A More by this author

Role:: Author
ORCID:: 0000-0001-8726-7186

+ Duncan, WC More by this author

Role:: Author
ORCID:: 0000-0002-7170-5740

+ Wallace, E More by this author

Role:: Author
ORCID:: 0000-0002-4506-5233

More authors...

Publisher:: BMJ Publishing Group
Journal:: BMJ Open More from this journal
Volume:: 3
Issue:: 7
Pages:: e002902-e002902
Publication date:: 2013-07-19
DOI:: 10.1136/bmjopen-2013-002902
EISSN:: 2044-6055
ISSN:: 2044-6055

Language:: English
Keywords:: Methotrexate

Ectopic pregnancy

Epidermal growth factor receptor

Clinical trial

Gefitinib

Oncology

Medicine

Cancer

Pharmacology

Internal medicine

Outpatient clinic

Pregnancy

Phases of clinical research
Pubs id:: 2370898
Local pid:: pubs:2370898
Source identifiers:: W2166719081
Deposit date:: 2026-02-14
ARK identifier:: ark:/29072/ora_b3c65bc384804da698d279f3d5ad5530

Terms of use

Copyright date:: 2013

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP